NIAID supports the study of global research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases and conditions. In addition to advancing these scientific goals, NIAID global research helps to improve the health of millions of people around the world, to protect the United States against infectious disease threats, and to promote international economic and political stability. Together, these efforts establish NIAID as a leader in global health.
Media Availability: Antiviral Favipiravir Successfully Treats Lassa Virus in Guinea Pigs—Oct. 13, 2015
Media Availability: NIH Scientists and Colleagues Successfully Test MERS Vaccine in Monkeys and Camels—Aug. 19, 2015
Media Availability: NIH-Developed Epstein-Barr Virus Vaccine Elicits Potent Neutralizing Antibodies in Animals—Aug. 13, 2015
NIH-Funded Study Establishes Genomic Data Set on Lassa Virus—Aug. 13, 2015
All Global Research News Releases
News From NIAID-Supported Institutions
Last Updated October 13, 2015